HLB Panagene Co Ltd
046210
Company Profile
Business description
HLB Panagene Co Ltd is a South Korea-based company that operates as a specialized bio venture company. The group is developing various technologies and products utilizing PNA (Peptide Nucleic Acid), an artificial gene.
Contact
54 Techno 10-ro
Yuseong-gu
Daejeon
KORT: +82 428619295
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
83
Stocks News & Analysis
stocks
This ASX miner is the cheapest in our iron ore coverage
High debt levels and low commodity prices were a concern, but agreed sell-downs and a ramp-up of key operations should help.
stocks
Apple names new CEO as Tim Cook steps aside after 15 years
John Ternus, Apple’s hardware chief, will take up the role in September.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,074.40 | 50.80 | -0.56% |
| CAC 40 | 8,210.76 | 24.95 | -0.30% |
| DAX 40 | 24,247.07 | 23.80 | -0.10% |
| Dow JONES (US) | 49,149.38 | 293.18 | -0.59% |
| FTSE 100 | 10,491.05 | 7.04 | -0.07% |
| HKSE | 26,163.24 | 324.24 | -1.22% |
| NASDAQ | 24,259.96 | 144.43 | -0.59% |
| Nikkei 225 | 59,585.86 | 236.69 | 0.40% |
| NZX 50 Index | 12,945.60 | 13.27 | 0.10% |
| S&P 500 | 7,064.01 | 0.00 | 0.00% |
| S&P/ASX 200 | 8,843.60 | 53.20 | -0.60% |
| SSE Composite Index | 4,106.26 | 21.18 | 0.52% |